Physician profile
Robert Marroquin
NPI 1255687885
$8,942.74
in general payments reported to CMS, 2019-2025
16 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,556 · 2020: $374 · 2021: $1,832 · 2022: $1,405 · 2023: $155 · 2024: $373 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortis Surgical, LLC | $3,381.51 | 2019-2021 | |
| Stryker Corporation | $3,164.72 | 2019-2022 | |
| Alon Medical Technology | $1,271.31 | 2022-2024 | |
| Depuy Synthes Sales INC. | $241.16 | 2024 | Motoband, Fibergraft Aeridyan Matrix, Fibergraft Bg Morsels |
| Treace Medical Concepts, INC. | $226.21 | 2024-2025 | |
| Orthofix Medical, INC. | $137.66 | 2022 | |
| Crossroads Extremity Systems, LLC | $107.87 | 2019-2021 | |
| Flower Orthopedics Coporation | $98.59 | 2023 | |
| Misonix INC | $84.19 | 2019-2021 | |
| Biocomposites INC | $60.14 | 2025 | Stimulan |
| Paratek Pharmaceuticals, INC. | $36.25 | 2022-2024 | Nuzyra |
| Lilly USA, LLC | $35.49 | 2023 | Mounjaro |
| Wright Medical Technology, INC. | $31.25 | 2020 | |
| Kerecis Limited | $29.56 | 2021 | |
| Averitas Pharma INC. | $23.20 | 2025 | Qutenza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Marroquin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.